By Mr Joseph Descallar

Conference Presentations

Short K; Eadie P; Descallar J; Comino E; Kemp L, 2016, 'The Gudaga Study: Risk and protective factors in longitudinal vocabulary development in urban Aboriginal chilren', presented at Longitudinal Data Conference, National Convention Centre, Canberra, 25 October 2016 - 27 October 2016

Padinharakam S; Chua W; Lim S; Karikios D; Adams D; Della-Fiorentina S; Desouza P; Moylan E; Harrison M; Descallar J; Balakrishnar B, 2015, 'Patterns of care and outcomes among sarcomatoid renal cell carcinoma patients in South Western Sydney'

Chan H; Kok P-S; Chao C; Descallar J; Bray V; Tognela A; Yip PY, 2015, 'Timing and patterns of referral to palliative care for patients with metastatic non-small cell cancer (NSCLC) in South Western Sydney Local Health District (SWSLHD)'

Kok PS; Chan H; Chao C; Descallar J; Bray V; Tognela A; Yip PY, 2015, '369O Timing of palliative care referral and its impact on receiving aggressive end of life care in patients with metastatic non-small cell lung cancer (NSCLC) in Southwest Sydney', http://dx.doi.org/10.1093/annonc/mdv531.02

Girgis A; Bonaventura T; Bonevski B; Hogan M; Boyes A; Proietto T; Ackland S; Crowley M; Descallar J, 2013, 'FEASIBILITY STUDY OF AN ONCOLOGY NURSE PRACTITIONER MODEL OF CARE IN A RURAL CANCER SETTING', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Watt S; Vinod SK; Dimigen M; Descallar J; Zogovic B; Atyeo J; Wallis S; Holloway L, 2013, 'INTER-OBSERVER VARIABILITY IN GROSS TUMOUR VOLUME DELINEATION ON KILO-VOLTAGE CONE BEAM COMPUTED TOMOGRAPHY (CBCT) SCANS FOR LUNG CANCER RADIOTHERAPY TREATMENT VERIFICATION', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339624901297&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Duggan KJ; Vinod SK; Descallar J, 2012, 'IS THERE A SURVIVAL BENEFIT IN THE RECEIPT OF GUIDELINE RECOMMENDED THERAPY IN NON METASTATIC NON SMALL CELL LUNG CANCER?', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310544400263&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page